For the week ending Saturday, March 10, 2018, these were the top five most viewed boards on the cafepharma forums:
- Daiichi-Sankyo - this also topped last week’s list. This week, employees were given notification about layoffs, and the board stayed active throughout the week.
- Shire - this also held the same position as last week. Discussions included more on the recent National Sales Meeting, Pfizer takeover rumors, and stock price/dividends.
- Amgen - Amgen moved up from fourth position last week. A lot of chatter surrounds the latest positive trial results for the rival drug Praluent, as well as competition from Esperion, and competition in the migraine market.
- Sanofi - Sanofi moved up from fifth position last week. Of course at the end of the week, the results from the ODYSSEY Praluent trial were a big discussion, but there was also this popular thread discussing the anxiety caused by the micromanagement of reps.
- AstraZeneca - AZ slides into the top five this week with discussions about the respiratory bio expansion, reviews and salary increases, and the Circle of Excellence.